Stryker Corporation vs. Treace Medical Concepts, Inc. Common Stock
SYK
Stryker Corporation
$327.81 -0.50%
VS TMCITreace Medical Concepts, Inc. Common Stock
$4.37 +0.69%
Stryker Corporation (SYK) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| SYK | TMCI | |
|---|---|---|
| Market Cap | $126.37 billion | $282.25 million |
| Revenue (TTM) | $25.84 billion | $205.31 million |
| Net Income (TTM) | $3.73 billion | $-59,516,000 |
SYK leads on 3 of 3 size & scale factors.
Valuation
| SYK | TMCI | |
|---|---|---|
| P/E Ratio | 33.97 | — |
| Price / Book | 5.27 | 4.17 |
| Price / Sales | 4.89 | 1.37 |
TMCI leads on 2 of 2 valuation factors.
Profitability
| SYK | TMCI | |
|---|---|---|
| Net Margin | 14.43% | -28.99% |
| Return on Equity | 15.55% | -87.86% |
SYK leads on 2 of 2 profitability factors.
Dividend
| SYK | TMCI | |
|---|---|---|
| Dividend Yield | 1.07% | — |
| Payout Ratio | 36.48 | — |
SYK and TMCI split the dividend factors evenly.
Risk & Sentiment
| SYK | TMCI | |
|---|---|---|
| Short Interest | 1.53% | 0.08% |
TMCI leads on 1 of 1 risk & sentiment factors.
Dig deeper: SYK overview, SYK financials, TMCI overview, TMCI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.